SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

ANI Pharmaceuticals Offers to Acquire Egetis Therapeutics

ANI Pharmaceuticals announced an offer to acquire Egetis Therapeutics, expanding its rare disease business.

ANIP
SquawkNews Desk 1 updates Updated Nov 05, 2026, 11:52 AM UTC

Story updates

11:52:51 AM UTC
SquawkNews
ANI Pharmaceuticals launched a recommended public offer for Egetis at SEK 11.25/share, valuing the e

Related stories

US Flights to Resume After Air Traffic Network Failure US flights are set to resume after an air traffic network failure disrupted operations. M impact | EQUITY | Nov 14, 2026, 08:06 AM UTC UniCredit Raises $3.5 Billion M impact | EQUITY | Nov 14, 2026, 08:03 AM UTC AMAT Shares Fall 2.58% as Headline Cites Record Q4 Revenue The headline also says 2027 demand is seen above 30%, but provides no further context. M impact | EQUITY | Nov 14, 2026, 08:02 AM UTC MSCI to Drop MSTR; CEO Sees Low Impact; $6.8B Bitcoin Loss M impact | EQUITY | Nov 14, 2026, 08:02 AM UTC IndiGo Says Global Microsoft Service Disruption Is Fully Resolved IndiGo said a global Microsoft service disruption affecting its email support services has been fully resolved. M impact | EQUITY | Nov 14, 2026, 07:36 AM UTC FAA Tech Failure Grounds Flights for Nearly Five Hours Air travel ground to a halt for almost five hours Friday after an overloaded air traffic control system failed, snarling operations at Sea-Tac. M impact | EQUITY | Nov 14, 2026, 07:32 AM UTC